This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Khan S, Gerber DE. Autoimmunity, checkpoint inhibitor therapy and immune-related adverse events: A review. Semin Cancer Biol. 2020;64,93–101.KhanSGerberDEAutoimmunity, checkpoint inhibitor therapy and immune-related adverse events: A review2020649310110.1016/j.semcancer.2019.06.012698044431330185Search in Google Scholar
Wang PF, Chen Y, Song SY et al. Immune-related adverse events associated with anti-PD-1/PD-L1 treatment for malignancies: A meta-analysis. Front Pharmacol. 2017;8,730.WangPFChenYSongSYImmune-related adverse events associated with anti-PD-1/PD-L1 treatment for malignancies: A meta-analysis2017873010.3389/fphar.2017.00730565153029093678Search in Google Scholar